Complex effects of Ras proto-oncogenes in tumorigenesis

Carcinogenesis

Volumn 25, Issue 4, 2004, Pages 535-539

  Diaz, Roberto ^a   Lopez Barcons, Lluis ^b   Ahn, Daniel ^a   Garcia Espana, Antonio ^c   Yoon, Andrew ^a   Matthews, Jeremy ^a   Mangues, Ramon ^d   Perez Soler, Roman ^b   Pellicer, Angel ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; METHYLNITROSOUREA; ONCOPROTEIN; RAS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CANCER INCIDENCE; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; FIBROSARCOMA; GENE OVEREXPRESSION; IN VIVO STUDY; KNOCKOUT MOUSE; LATENT PERIOD; MALE; MOUSE; NONHUMAN; ONCOGENE N RAS; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL; STROMA CELL; WILD TYPE;

ANIMALS; CARCINOGENS; CELL LINE, TUMOR; FIBROSARCOMA; GENES, RAS; LYMPHOMA, B-CELL; MALE; MAMMARY TUMOR VIRUS, MOUSE; METHYLNITROSOUREA; MICE; MICE, KNOCKOUT; NEOPLASMS;

EID: 1942436234     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh026     Document Type: Article

References (31)

1. Malumbres,M. and Pellicer,A. (1998) RAS pathways to cell cycle control and cell transformation. Front. Biosci., 3, d887-912.
2. Adjei,A.A. (2001) Blocking oncogenic Ras signaling for cancer therapy. J. Natl Cancer Inst., 93, 1062-1074.
3. Barbacid,M. (1987) ras genes. Annu. Rev. Biochem., 56, 779-827.
4. Bos,J.L. (1997) Ras-like GTPases. Biochim. Biophys. Acta, 1333, M19-31.
5. Spandidos,D.A., Sourvinos,G., Tsatsanis,C. and Zafiropoulos,A. (2002) Normal ras genes: their onco-suppressor and pro-apoptotic functions (Review). Int. J. Oncol., 21, 237-241.
6. Campbell,S.L., Khosravi-Far,R., Rossman,K.L., Clark,G.J. and Der,C.J. (1998) Increasing complexity of Ras signaling. Oncogene, 17, 1395-1413.
7. Rebollo,A. and Martinez,A.C. (1999) Ras proteins: recent advances and new functions. Blood, 94, 2971-2980. 8 Ayllon,V. and Rebollo,A. (2000) Ras-induced cellular events (review). Mol. Membr. Biol., 17, 65-73.
8. Khosravi-Far,R., Campbell,S., Rossman,K.L. and Der,C.J. (1998) Increasing complexity of Ras signal transduction: involvement of Rho family proteins. Adv. Cancer Res., 72, 57-107.
9. Kauffmann-Zeh,A., Rodriguez-Viciana,P., Ulrich,E., Gilbert,C., Coffer,P., Downward,J. and Evan,G. (1997) Suppression of c-Myc-induced apoptosis by Ras signalling through PI (3)K and PKB. Nature, 385, 544-548.
10. Khokhlatchev,A., Rabizadeh,S., Xavier,R., Nedwidek,M., Chen,T., Zhang,X.F., Seed,B. and Avruch,J. (2002) Identification of a novel Ras-regulated proapoptotic pathway. Curr. Biol., 12, 253-265.
11. Kennedy,S.G., Wagner,A.J., Conzen,S.D., Jordan,J., Bellacosa,A., Tsichlis,P.N. and Hay,N. (1997) The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev., 11, 701-713.
12. Zhang,Z., Wang,Y., Vikis,H.G. et al. (2001) Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nature Genet., 29, 25-33.
13. Diaz,R., Ahn,D., Lopez-Barcons,L. et al. (2002) The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. Cancer Res., 62, 4514-4518.
14. James,R.M., Arends,M.J., Plowman,S.J., Brooks,D.G., Miles,C.G., West,J.D. and Patek,C.E. (2003) K-ras proto-oncogene exhibits tumor suppressor activity as its absence promotes tumorigenesis in murine teratomas. Mol. Cancer Res., 1, 820-825.
15. Ise,K., Nakamura,K., Nakao,K., Shimizu,S., Harada,H., Ichise,T., Miyoshi,J., Gondo,Y., Ishikawa,T., Aiba,A. and Katsuki,M. (2000) Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. Oncogene, 19, 2951-2956.
16. Liu,M.L., Shibata,M.A., Von Lintig,F.C., Wang,W., Cassenaer,S., Boss,G.R. and Green,J.E. (2001) Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice. Oncogene, 20, 2044-2049.
17. Thompson,T.A., Haag,J.D., Lindstrom,M.J., Griep,A.E., Lohse,J.K. and Gould,M.N. (2002) Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter. Oncogene, 21, 2797-2804.
18. Mangues,R., Kahn,J.M., Seidman,I. and Pellicer,A. (1994) An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis. Cancer Res., 54, 6395-6401.
19. Asamoto,M., Ochiya,T., Toriyama-Baba,H., Ota,T., Sekiya,T., Terada,M. and Tsuda,H. (2000) Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis. Carcinogenesis, 21, 243-249.
20. Ota,T., Asamoto,M., Toriyama-Baba,H., Yamamoto,F., Matsuoka,Y., Ochiya,T., Sekiya,T., Terada,M., Akaza,H. and Tsuda,H. (2000) Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis. Carcinogenesis, 21, 1391-1396.
21. Tsuda,H., Asamoto,M., Ochiya,T., Toriyama-Baba,H., Naito,A., Ota,T., Sekiya,T. and Terada,M. (2001) High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis. Mutat. Res., 477, 173-182.
22. Asamoto,M., Toriyama-Baba,H., Ohnishi,T., Naito,A., Ota,T., Ando,A., Ochiya,T. and Tsuda,H. (2002) Transgenic rats carrying human c-Ha-ras proto-oncogene are highly susceptible to N-nitrosomethylbenzylamine induction of esophageal tumorigenesis. Jpn. J. Cancer Res., 93, 744-751.
23. Elenbaas,B., Spirio,L., Koerner,F., Fleming,M.D., Zimonjic,D.B., Donaher,J.L., Popescu,N.C., Hahn,W.C. and Weinberg,R.A. (2001) Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev., 15, 50-65.
24. Umanoff,H., Edelmann,W., Pellicer,A. and Kucherlapati,R. (1995) The murine N-ras gene is not essential for growth and development. Proc. Natl Acad. Sci. USA, 92, 1709-1713.
25. Mangues,R., Symmans,W.F., Lu,S., Schwartz,S. and Pellicer,A. (1996) Activated N-ras oncogene and N-ras proto-oncogene act through the same pathway for in vivo tumorigenesis. Oncogene, 13, 1053-1063.
26. Mangues,R., Seidman,I., Pellicer,A. and Gordon,J.W. (1990) Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene. Oncogene, 5, 1491-1497.
27. Malumbres,M., Mangues,R., Ferrer,N., Lu,S. and Pellicer,A. (1997) Isolation of high molecular weight DNA for reliable genotyping of transgenic mice. Biotechniques, 22, 1114-1119.
28. Niwa,O., Enoki,Y. and Yokoro,K. (1989) Overexpression and amplification of the c-myc gene in mouse tumors induced by chemicals and radiations. Jpn. J. Cancer Res., 80, 212-218.
29. Llorens,A., Rodrigo,I., Lopez-Barcons,L., Gonzalez-Garrigues,M., Lozano,E., Vinyals,A., Quintanilla,M., Cano,A. and Fabra,A. (1998) Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. Lab. Invest., 78, 1131-1142.
30. Mangues,R., Corral,T., Lu,S., Symmans,W.F., Liu,L. and Pellicer,A. (1998) NF1 inactivation cooperates with N-ras in in vivo lymphogenesis activating Erk by a mechanism independent of its Ras-GTPase accelerating activity. Oncogene, 17, 1705-1716.
31. MacKenzie,K.L., Dolnikov,A., Millington,M., Shounan,Y. and Symonds,G. (1999) Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice. Blood, 93, 2043-2056